Literature DB >> 19904209

Variability in interpreting and reporting copy number changes detected by array-based technology in clinical laboratories.

Karen D Tsuchiya1, Lisa G Shaffer, Swaroop Aradhya, Julie M Gastier-Foster, Ankita Patel, M Katharine Rudd, Julie Sanford Biggerstaff, Warren G Sanger, Stuart Schwartz, James H Tepperberg, Erik C Thorland, Beth A Torchia, Arthur R Brothman.   

Abstract

PURPOSE: : The purpose of this study was to assess the variability in interpretation and reporting of copy number changes that are detected by array-based technology in the clinical laboratory.
METHODS: : Thirteen different copy number changes, detected by array comparative genomic hybridization, that have not been associated with an abnormal phenotype in the literature were evaluated by directors from 11 different clinical laboratories to determine how they would interpret and report the findings.
RESULTS: : For none of the thirteen copy number changes was there complete agreement in the interpretation of the clinical significance of the deletion or duplication. For some cases, the interpretations ranged from normal to abnormal.
CONCLUSION: : There is a need for more specific guidelines for interpreting and reporting copy number changes detected by array-based technology to clearly and more consistently communicate the clinical significance of these findings to ordering providers.

Entities:  

Mesh:

Year:  2009        PMID: 19904209     DOI: 10.1097/GIM.0b013e3181c0c3b0

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  22 in total

1.  Practical considerations to guide development of access controls and decision support for genetic information in electronic medical records.

Authors:  Diana C Darcy; Eleanor T Lewis; Kelly E Ormond; David J Clark; Jodie A Trafton
Journal:  BMC Health Serv Res       Date:  2011-11-02       Impact factor: 2.655

2.  Phenotypic information in genomic variant databases enhances clinical care and research: the International Standards for Cytogenomic Arrays Consortium experience.

Authors:  Erin Rooney Riggs; Laird Jackson; David T Miller; Steven Van Vooren
Journal:  Hum Mutat       Date:  2012-03-20       Impact factor: 4.878

3.  Variants of unknown significance on chromosomal microarray analysis: parental perspectives.

Authors:  Stephanie Jez; Megan Martin; Sarah South; Rena Vanzo; Erin Rothwell
Journal:  J Community Genet       Date:  2015-02-10

4.  Rare deletions at the neurexin 3 locus in autism spectrum disorder.

Authors:  Andrea K Vaags; Anath C Lionel; Daisuke Sato; McKinsey Goodenberger; Quinn P Stein; Sarah Curran; Caroline Ogilvie; Joo Wook Ahn; Irene Drmic; Lili Senman; Christina Chrysler; Ann Thompson; Carolyn Russell; Aparna Prasad; Susan Walker; Dalila Pinto; Christian R Marshall; Dimitri J Stavropoulos; Lonnie Zwaigenbaum; Bridget A Fernandez; Eric Fombonne; Patrick F Bolton; David A Collier; Jennelle C Hodge; Wendy Roberts; Peter Szatmari; Stephen W Scherer
Journal:  Am J Hum Genet       Date:  2011-12-29       Impact factor: 11.025

5.  The laboratory-clinician team: a professional call to action to improve communication and collaboration for optimal patient care in chromosomal microarray testing.

Authors:  Karen E Wain; Erin Riggs; Karen Hanson; Melissa Savage; Darlene Riethmaier; Andrea Muirhead; Elyse Mitchell; Bethanny Smith Packard; W Andrew Faucett
Journal:  J Genet Couns       Date:  2012-05-18       Impact factor: 2.537

Review 6.  Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.

Authors:  David T Miller; Margaret P Adam; Swaroop Aradhya; Leslie G Biesecker; Arthur R Brothman; Nigel P Carter; Deanna M Church; John A Crolla; Evan E Eichler; Charles J Epstein; W Andrew Faucett; Lars Feuk; Jan M Friedman; Ada Hamosh; Laird Jackson; Erin B Kaminsky; Klaas Kok; Ian D Krantz; Robert M Kuhn; Charles Lee; James M Ostell; Carla Rosenberg; Stephen W Scherer; Nancy B Spinner; Dimitri J Stavropoulos; James H Tepperberg; Erik C Thorland; Joris R Vermeesch; Darrel J Waggoner; Michael S Watson; Christa Lese Martin; David H Ledbetter
Journal:  Am J Hum Genet       Date:  2010-05-14       Impact factor: 11.025

7.  Evaluation of the Affymetrix CytoScan(®) Dx Assay for developmental delay.

Authors:  Bryn D Webb; Rebecca J Scharf; Emily A Spear; Lisa J Edelmann; Annemarie Stroustrup
Journal:  Expert Rev Mol Diagn       Date:  2014-10-28       Impact factor: 5.225

8.  Diagnostic interpretation of array data using public databases and internet sources.

Authors:  Nicole de Leeuw; Trijnie Dijkhuizen; Jayne Y Hehir-Kwa; Nigel P Carter; Lars Feuk; Helen V Firth; Robert M Kuhn; David H Ledbetter; Christa Lese Martin; Conny M A van Ravenswaaij-Arts; Steven W Scherer; Soheil Shams; Steven Van Vooren; Rolf Sijmons; Morris Swertz; Ros Hastings
Journal:  Hum Mutat       Date:  2012-06       Impact factor: 4.878

9.  Clinical interpretation of CNVs with cross-species phenotype data.

Authors:  Sebastian Köhler; Uwe Schoeneberg; Johanna Christina Czeschik; Sandra C Doelken; Jayne Y Hehir-Kwa; Jonas Ibn-Salem; Christopher J Mungall; Damian Smedley; Melissa A Haendel; Peter N Robinson
Journal:  J Med Genet       Date:  2014-10-03       Impact factor: 6.318

Review 10.  Clinical impact of copy number variation analysis using high-resolution microarray technologies: advantages, limitations and concerns.

Authors:  Curtis R Coughlin; Gunter H Scharer; Tamim H Shaikh
Journal:  Genome Med       Date:  2012-10-30       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.